FindTrial
Sign In

The value of transitory protective stoma in primary debulking surgery of advanced epithelial ovarian cancer

The value of transitory protective stoma in primary debulking surgery of advanced epithelial ovarian cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060453
Enrollment
Unknown
Registered
2022-06-01
Start date
2022-05-22
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian malignant tumor

Interventions

Control group 2:Routine surgical treatment
Experimental group:Transitory protective stoma was performed during operation
Control group 1:Intestinal resection and anastomosis were performed during operation

Sponsors

Shengjing Hospital, China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. International Federation of Obstetrics and Gynecology (FIGO) Stage III-IV epithelial ovarian cancer patients; 2. Infiltrating growth mass in posterior pelvic cavity was confirmed intraoperatively; 3. Radiotherapy and chemotherapy were not performed before surgery.

Exclusion criteria

Exclusion criteria: Patients with non-epithelial histology, neoadjuvant chemotherapy, or incomplete medical records.

Design outcomes

Primary

MeasureTime frame
Progression-free survival;The incidence of complications;—

Countries

China

Contacts

Public ContactOuyang Ling

Shengjing Hospital, China Medical University

ouyang1964@163.com+86 18940251964

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026